Lecture 2 Flashcards

1
Q

When did scientific trials begin?

A

in the 1930s

statistics were introduced into scientific clinical trials in 1937.
–> trials not monitored for ethical principles and safety of subjects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What incident in 1930s leads to pharmaceutical companies carrying out scientific trials?

A

In 1937, Sulphanilamide elixir (an antibiotic) was manufactured using diethylene glycol (a toxic medium)
–> 105 deaths

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What act was introduced by the government in 1938 following the sandal of ‘sulphanilamide’?

A

The Food, Drug and Cosmetic Act

-new drug application report
-review tests
-demonstrate drug safety
-formula disclosing all ingredients
-directions for use and warnings about
misuse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What act relating to human experimentation was introduced in 1947 following the world war II?

A

The Nuremberg Code

It set the standard for medical experimentation on human Subjects
–> consent essential
–> benefit of research outweigh risks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Briefly explain the Thalimode disaster that occured in 1950s.

A

-launched as a sleeping tablet ‘Contergan’ by Chemie Grnenthal in 1957
-sold in over 40 countries under license
-US had not given licensing approval
-caused birth defects in 10,000 to 20,000 babies
-withdrawn from most markets in 1961

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

In what ways does the Nuremberg Code introduced in 1947 protect human subjects in scientific trials?

A

Introduced the requirements for obtaining informed consent
-Voluntary
-Right to withdraw
-Avoid unnecessary physical and mental suffering

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

State 2 incidents in the 20th century where the rights of clinical subjects were violated.

A
  1. World War II 1939-1945 nazi medical
    experiments
  2. Tuskegee sharecroppers USA (1932-
    1972)
    –> long-term study of untreated syphilis
    –> 600 low-income African Americans
    males, 400 infected with syphilis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What act did the US government introduced in 1962 following the thalidomide incident?

A

Kefauver-Harris Drug Amendments (1962)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

State the contributions and outcomes of Decleration of Helsinki intorduced in 1964?

A

-Recognized as the gold standard for conducting research
-World Medical Association
-1st attempt of medical community to regulate itself

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the contribution of Belmont report and when was it released?

A

in 1979
Three fundamental ethical principles
1. Respect for others
2. Beneficence
3. Justice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the 3 fundamental ethical principles of the Belmont Report?

A
  1. Respect for others
  2. Beneficence
  3. Justice
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

When were the ICH GCP Guidlines first introduced?

A

1996

ICH - internatioal council of humanisation
GCP - good clinical practice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

When was ICH founded?

A

April 1990

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Who were the initial ICH parties?

A

EU, US and Japan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Who were the initial ICH observrs?

A

WHO
European free trade association (EFTA)
Canada

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

When did ICH further expand and what countries were invited to join?

A

2007

Countries with a history of ICH guideline implementation and/or where major production and clinical research are done (Australia, Brazil, China, Chinese, Taipei, India, Republic of Korea, Russia and Singapore)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the 2 types of applications for marketing of pharmaceutical products?

A

New Drug Application (NDA)

Market Authorization Application (MAA)

18
Q

What is INDs and what is it for?

A

Investigational New Drug Applications

–>for clinical trial authorization from FDA
–> safety and efficacy of drug examined

19
Q

What kind of content does an IND application need?

A

-protocol
-Chemistry, Manufacturing and Control
Data
-Pharmacology and Toxicology Data
-previous human experience

20
Q

What is the general sequence of events leading to clinical study approval?

A
  1. protocol finalization
  2. investigator selection
  3. IRB/IEC approval
  4. Regulatory approval
  5. import license (if applicable)
21
Q

What is CTA?

A

clinical trial authoriation

-needed to run clinical trials in HK for new drugs

22
Q

What is the sequence of events leading to getting CTA (clinical trial authorization) for new drugs in HK?

A

Receipt of clinical documents required. Translated.

Simultaneously,
–> submitted by PI to hospital IRB for
review
–> submitted by CRO to DoH for approval

Application by CRO for import license

*DoH only approve after green light from IRB

23
Q

How long does the CTA process take in Hong Kong?

A

3-4 months

24
Q

What is the content of NDA?

A

-chemistry
-nonclinical toxicology
-human PK and bioavailability
-clinical microbiology
-clinical data
-case reports
-patent info

25
Q

What does MAA in HK need to include?

A
  1. GMP certificate
  2. free sale certificate from country of
    origin
  3. outer pack photo
  4. copy of relevant licenses (poison,
    antibiotic etc)
26
Q

What is Good Clinical Practice (GCP)

A

A standard for
1.design
2. conduct
3. performance
4. monitoring,
5. auditing
6. recording
7. analyses and
8. reporting
of clinical trials that provides assurance that data and reported results are credible and accurate and that the rights, integrity and confidentiality of trial subjects are protected

27
Q

Why regulate clincal research?

A
  1. To ensure the rights, safety and well-being of human subjects
  2. To ensure scientific integrity
28
Q

Why follow GCP?

A
  1. Subjects are properly protected in studies
  2. Studies are based on good science, are well designed and properly analysed
  3. Study procedures are properly undertaken and documented
29
Q

What do the principles of ICH GCP include?

A
  1. ethics
  2. protocol and sciences
  3. responsibilties
  4. informed data quality/integrity
  5. QC/QA
30
Q

What are the responsible parties regarding clinical paractice?

A
  1. study sponsor/ contract research
    organisation (CRO)
  2. Clinical investigators (CI)
  3. independent ethics committee (IEC)/
    independent review board (IRB)
31
Q

What is a sponsor?

A

An individual, company, institution, or organisation that takes responsibility for the initiation, management, and/or financing of a clinical trial

32
Q

Who could be sponsor?

A
  1. commercial (pharmaceutical and
    device) companies
  2. government
  3. funding agencies
  4. private foundations
  5. individuals
33
Q

GCP requires certain direct communications and interactions between the sponsor and the
regulatory authority.

True or false.

34
Q

What is CRO (contract research organisation) and what are its duties?

A

A person or an organisation (commercial
academic, or other) contracted by the
sponsor to perform one or more of a
sponsor’s trial-related duties and functions.

–> responsible for the conduct of thes study

35
Q

What is a monitor and what are his/her duties in a clinical trial?

A

Employee of the sponsor (or CRO) who oversees the progress of a clinical study through on-site visits and other means

–> to ensure conducted, recorded, and
reported in accordance with the protocol, SOPs, GCP and the applicable regulatory requirements(s).

36
Q

What is a Medical Expert (medical monitor)?

A

Employee of the sponsor (or CRO) who is readily available to advise on trial-
related medical questions or problems

*If neccessary outside consultants may be appointed

37
Q

What is DMC/DSMB?

A

Independent Data Monitoring Committee

38
Q

What is the purpose of DMC/DSMB?

A

A committee established by, but acting
independent of, the sponsor to assess at
intervals the progress of a clinical trial, the
safety data, and the critical efficacy endpoints, and to recommend to the sponsor whether to continue, modify or stop a trial

39
Q

What are the key responsibilities of a sponsor?

A
  1. Obtain regulatory approval before
    initiating a study
  2. Manufacture and label investigational
    products appropriately
  3. Initiate, withhold, or discontinue studies
    –> Includes protocol development,
    often in consultation with one or
    more clinical investigators
    –> select investigators
    –> select qualified persons to monitor
    study
    –> report adverse experiences and
    maintain records